Skip to main content

The Role of Chromoendoscopy and Enhanced Imaging Techniques in Inflammatory Bowel Disease Colorectal Cancer Colonoscopy Surveillance

  • Chapter
  • First Online:
Diagnostic and Therapeutic Procedures in Gastroenterology

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

Patients with a long-standing ulcerative colitis (UC) and extensive Crohn’s disease (CD) colitis have an approximately twofold higher risk of developing colorectal cancer. Increased duration and extent of colonic involvement contribute to the level of risk and unfortunately are not modifiable. A majority of gastrointestinal professional societies have recommended colonoscopy for the surveillance of patients with inflammatory bowel disease (IBD). Despite surveillance, IBD patients with colitis continue to be at risk for colorectal cancer secondary to missed and unrecognized dysplastic lesions at colonoscopy. Until recently, the random sampling of mucosa throughout the colon has been the primary method of surveillance. This approach to colonoscopy surveillance in IBD has been ineffective, time-consuming, and expensive and has a low diagnostic yield. According to the latest studies, most dysplastic lesions are visible to careful endoscopic inspection. This has led to a more focused approach in surveillance colonoscopy, mainly targeted biopsies of any mucosal abnormalities using chromoendoscopy (CE) and other enhanced imaging techniques including high-definition endoscopy, confocal laser endomicroscopy, endocytoscopy, and molecular imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Friedman S, Rubin PH, Bodian C, Goldstein E, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic crohn's colitis. Gastroenterology. 2001;120(4):820–6.

    Article  CAS  PubMed  Google Scholar 

  3. Friedman S, Rubin PH, Bodian C, Harpaz N, Present DH. Screening and surveillance colonoscopy in chronic crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol. 2008;6(9):993–8. quiz 953-4.

    Article  PubMed  Google Scholar 

  4. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10(6):639–45.

    Article  PubMed  Google Scholar 

  5. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56(1):48–54.

    Article  PubMed  Google Scholar 

  6. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126(2):451–9.

    Article  PubMed  Google Scholar 

  7. Rubin DT, Huo D, Kinnucan JA, et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clin Gastroenterol Hepatol. 2013;11(12):1601–8.e1-4.

    Article  PubMed  Google Scholar 

  8. Krugliak Cleveland N, Colman RJ, Rodriquez D, et al. Surveillance of IBD using high definition colonoscopes does not miss adenocarcinoma in patients with low-grade dysplasia. Inflamm Bowel Dis. 2016;22(3):631–7.

    Article  PubMed  Google Scholar 

  9. Itzkowitz S. Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol. 2003;36(5 Suppl):S70–4. discussion S94-6.

    Article  CAS  PubMed  Google Scholar 

  10. Brentnall TA, Crispin DA, Rabinovitch PS, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology. 1994;107(2):369–78.

    Article  CAS  PubMed  Google Scholar 

  11. Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7(12):982–1018.

    Article  PubMed  Google Scholar 

  12. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):738–45.

    Article  PubMed  Google Scholar 

  13. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81(3):489–501.e26.

    Article  PubMed  Google Scholar 

  14. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148(3):639–651.e28.

    Article  PubMed  Google Scholar 

  15. Leighton JA, Shen B, Baron TH, et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. 2006;63(4):558–65.

    Article  PubMed  Google Scholar 

  16. Sanduleanu S, Kaltenbach T, Barkun A, et al. A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016;83(1):213–22.

    Article  PubMed  Google Scholar 

  17. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130(4):1030–8.

    Article  PubMed  Google Scholar 

  18. Jaramillo E, Watanabe M, Befrits R, Ponce de Leon E, Rubio C, Slezak P. Small, flat colorectal neoplasias in long-standing ulcerative colitis detected by high-resolution electronic video endoscopy. Gastrointest Endosc. 1996;44(1):15–22.

    Article  CAS  PubMed  Google Scholar 

  19. Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc. 2007;65(7):998–1004.

    Article  PubMed  Google Scholar 

  20. Soetikno R, Sanduleanu S, Kaltenbach T. An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2014;24(3):483–520.

    Article  PubMed  Google Scholar 

  21. Technology Committee ASGE. High-definition and high-magnification endoscopes. Gastrointest Endosc. 2014;80(6):919–27.

    Article  Google Scholar 

  22. Subramanian V, Ramappa V, Telakis E, et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(2):350–5.

    Article  PubMed  Google Scholar 

  23. Bartel MJ, Picco MF, Wallace MB. Chromocolonoscopy. Gastrointest Endosc Clin N Am. 2015;25(2):243–60.

    Article  PubMed  Google Scholar 

  24. ASGE Technology Committee, Wong Kee Song LM, Adler DG, et al. Chromoendoscopy. Gastrointest Endosc. 2007;66(4):639–49.

    Article  Google Scholar 

  25. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53(2):256–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Deepak P, Hanson GJ, Fletcher JG, et al. Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopy. Gastrointest Endosc. 2016;83(5):1005–1012.

    Google Scholar 

  27. Konijeti GG, Shrime MG, Ananthakrishnan AN, Chan AT. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc. 2014;79(3):455–65.

    Article  PubMed  Google Scholar 

  28. Soetikno R, Subramanian V, Kaltenbach T, et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology. 2013;144(7):1349–52. 1352.e1–6.

    Article  PubMed  Google Scholar 

  29. van den Broek FJ, Stokkers PC, Reitsma JB, et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol. 2014;109(5):715–22.

    Article  PubMed  Google Scholar 

  30. Neumann H, Kiesslich R, Wallace MB, Neurath MF. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology. 2010;139(2):388–92. 392.e1–2.

    Article  PubMed  Google Scholar 

  31. Su P, Liu Y, Lin S, et al. Efficacy of confocal laser endomicroscopy for discriminating colorectal neoplasms from non-neoplasms: a systematic review and meta-analysis. Color Dis. 2013;15(1):e1–12.

    Article  CAS  Google Scholar 

  32. Rasmussen DN, Karstensen JG, Riis LB, Brynskov J, Vilmann P. Confocal laser endomicroscopy in inflammatory bowel disease--a systematic review. J Crohns Colitis. 2015;9(12):1152–9.

    Article  PubMed  Google Scholar 

  33. Neumann H, Fuchs FS, Vieth M, et al. Review article: in vivo imaging by endocytoscopy. Aliment Pharmacol Ther. 2011;33(11):1183–93.

    Article  CAS  PubMed  Google Scholar 

  34. Neumann H, Vieth M, Neurath MF, Atreya R. Endocytoscopy allows accurate in vivo differentiation of mucosal inflammatory cells in IBD: a pilot study. Inflamm Bowel Dis. 2013;19(2):356–62.

    Article  PubMed  Google Scholar 

  35. Atreya R, Neumann H, Neufert C, et al. In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in crohn's disease. Nat Med. 2014;20(3):313–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Humberto Sifuentes .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ayoola, R., Mohanty, M., Lee, J.E., Sifuentes, H. (2018). The Role of Chromoendoscopy and Enhanced Imaging Techniques in Inflammatory Bowel Disease Colorectal Cancer Colonoscopy Surveillance. In: Sridhar, S., Wu, G. (eds) Diagnostic and Therapeutic Procedures in Gastroenterology. Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-62993-3_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62993-3_25

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-62991-9

  • Online ISBN: 978-3-319-62993-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics